Plain-English translation of NCT05378035 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how four blood clot-preventing medications (apixaban, dabigatran, edoxaban, and rivaroxaban) behave in Chinese patients' bodies. When you need to pause one of these medications before a medical procedure like a colonoscopy or heart catheterization, the study team will take blood samples to measure medication levels at different time points after you stop taking it.
Right now, Western guidelines recommend stopping these medications 48 hours before procedures, but the researchers think the medication may work differently in Asian patients and that 24 hours might be enough. This study aims to find out whether stopping the medication for just 24 hours instead of 48 could be safe for Chinese patients.
You likely qualify if…
You likely don't qualify if…
When you come in for your scheduled medical procedure, the study team will take blood samples from you at four different time points: at the peak level of your medication, at its lowest level, and 24 and 48 hours after you stop taking it. They will also collect basic health information like your blood pressure, weight, medical history, and a list of all your current medications. The entire process takes place around your regular medical procedure appointment and should not add significantly to your visit time.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Hong Kong